Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study.
Lim J, Eftimov F, Verhamme C, Brusse E, Hoogendijk JE, Saris CGJ, Raaphorst J, De Haan RJ, van Schaik IN, Aronica E, de Visser M, van der Kooi AJ.
Lim J, et al. Among authors: de visser m, de haan rj.
Rheumatology (Oxford). 2021 Apr 6;60(4):1784-1792. doi: 10.1093/rheumatology/keaa459.
Rheumatology (Oxford). 2021.
PMID: 33099648
Free PMC article.
Clinical Trial.